Last Posted: Feb 13, 2020
- An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie Fei et al. Molecular medicine reports 2019 Oct 20(4) 2990-3002 - Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
Gu Yulan et al. PloS one 2020 (2) e0224001 - Cross-Dataset Evaluation of Deep Learning Networks for Uterine Cervix Segmentation.
Guo Peng et al. Diagnostics (Basel, Switzerland) 2020 Jan 10(1) - Identification and validation of a prognostic proteomic signature for cervical cancer.
Rader Janet S et al. Gynecologic oncology 2019 155(2) 324-330 - Revisiting the Genomic and Transcriptomic Landscapes From Female Malignancies Could Provide Molecular Markers and Targets for Precision Medicine.
Taniguchi-Ponciano Keiko et al. Archives of medical research 2019 Nov 50(7) 428-436 - A Patient's Guide to Endometrial Cancer-This cancer is on the rise. But early detection saves lives.
MO Shroeder, US News, October 4, 2019 - Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer Wieke W et al. Journal of the International AIDS Society 2018 21(8) e25165 - Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population.
Wong Oscar G W et al. Journal of clinical microbiology 2019 Sep - Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew Jie-Bin et al. Public health research & practice 2019 Jul 29(2) - Validation of New High Throughput, Low Cost HPV Test for Cervical Cancer Prevention
NCI, August 6, 2019
.jpeg)
No hay comentarios:
Publicar un comentario